News

Treace Medical Concepts Earnings Preview: What to Expect Soon

Treace Medical Concepts Earnings Preview: What to Expect Soon

Treace Medical Concepts Earnings Preview: What to Expect Soon

Treace Medical Concepts (NASDAQ: TMCI) is set to unveil its quarterly earnings report shortly. Investors are keenly anticipating this release with hopes that it will surpass estimates and provide a positive outlook for the coming quarter. Analysts have forecasted an earnings per share (EPS) of $-0.27 for the upcoming report.

This state of anticipation is critical as it can significantly influence stock prices. New investors should remember that market sentiment often leans towards future projections rather than solely reflecting past performance.

Overview of Past Earnings

In the last quarter, Treace Medical Concepts faced a challenge, reporting an EPS lower than forecasts by $0.05, which resulted in a 2.4% drop in its share price the next day. Such market reactions are critical for long-term shareholders to acknowledge.

A dive into the past performances reveals significant fluctuations in Treace Medical Concepts’s earnings:

  • Q2 2024: Estimated EPS: -0.29, Actual EPS: -0.34, Price change: -2.0%
  • Q1 2024: Estimated EPS: -0.3, Actual EPS: -0.3, Price change: -62.0%
  • Q4 2023: Estimated EPS: -0.09, Actual EPS: -0.1, Price change: -6.0%
  • Q3 2023: Estimated EPS: -0.26, Actual EPS: -0.28, Price change: -38.0%

Performance of Treace Medical Concepts Shares

As of November 1, shares of Treace Medical Concepts are trading around $4.78. This marks a significant decrease of approximately 50.9% over the last year. The negative returns could leave long-term shareholders feeling anxious as they look forward to the upcoming earnings announcement.

Analyst Insights on Treace Medical Concepts

Understanding the prevailing market sentiment and forecasts can be essential for stakeholders. According to analysts, Treace Medical Concepts holds a consensus rating of Neutral based on three ratings, with an average one-year price target of $6.83, suggesting a promising potential upside of around 42.89%.

Analyzing Ratings Among Peers

When considering Treace Medical Concepts alongside its peers—Tactile Systems Tech, ClearPoint Neuro, and Delcath Systems—you can gain insight into their competitive positioning:

  • Tactile Systems Tech has an analyst consensus rating of Buy, with a projected price target of $23.0, revealing an impressive potential upside of 381.17%.
  • ClearPoint Neuro also has a Buy rating with a target price of $15.0, indicating a good upside of 213.81%.
  • Delcath Systems carries a Buy consensus, with a target of $22.5, presenting an upside of 370.71%.

Analysis Summary for Peers

A comparative analysis of key metrics reveals Treace Medical Concepts struggles in revenue growth and gross profit, ranking at the bottom relative to its peers. Such metrics are pivotal for stakeholders to consider when assessing the company’s market standing.

Summarizing key metrics:

  • Treace Medical Concepts: Revenue Growth: 5.96%, Gross Profit: $35.67M, Return on Equity: -17.78%
  • Tactile Systems Tech: Revenue Growth: 7.14%, Gross Profit: $54.10M, Return on Equity: 2.18%
  • ClearPoint Neuro: Revenue Growth: 32.07%, Gross Profit: $4.99M, Return on Equity: -13.21%
  • Delcath Systems: Revenue Growth: 1468.89%, Gross Profit: $6.25M, Return on Equity: -146.09%

Discovering Treace Medical Concepts: A Closer Look

Treace Medical Concepts Inc is an innovative company in the orthopaedic medical device sector, concentrating on enhancing surgical solutions for bunion deformities. The Lapiplasty 3D Bunion Correction procedure stands out as it comprehensively addresses the underlying issues of bunion deformities and promotes quick recovery for patients. This unique focus sets Treace Medical Concepts apart in a competitive landscape.

Financial Milestones: Treace Medical Concepts's Journey

Market Capitalization: Treace Medical's market capitalization remains below industry averages, potentially limiting its expansion and investment capacity.

Revenue Growth: The company has recorded a revenue growth of 5.96% for the recent quarter ending June 30, 2024, but this is still below what is typical in the Health Care sector.

Net Margin: Treace Medical Concepts demonstrates a net margin of -47.7%, pointing to areas for operational improvement and cost efficiency.

Return on Equity (ROE): The company's ROE, at -17.78%, reflects potential concerns about utilizing equity capital effectively.

Return on Assets (ROA): With an ROA of -9.05%, Treace Medical Concepts may find it challenging to extract optimal returns from asset investments.

Debt Management: Favorably, Treace Medical Concepts showcases a debt-to-equity ratio of 0.62, highlighting a strong financial position relative to industry norms.

Frequently Asked Questions

What is the expected EPS for Treace Medical Concepts?

The expected EPS for Treace Medical Concepts is $-0.27 for the upcoming earnings report.

How did Treace Medical Concepts perform last quarter?

Last quarter, Treace Medical Concepts reported an EPS that missed estimates by $0.05, leading to a drop in share price.

What is the current stock price of Treace Medical Concepts?

As of November 1, the stock price of Treace Medical Concepts is $4.78.

What is the analyst rating for Treace Medical Concepts?

Treace Medical Concepts has a consensus rating of Neutral among analysts.

How does Treace Medical Concepts compare to its competitors?

Compared to its competitors, Treace Medical Concepts ranks lower in revenue growth and gross profit, indicating room for improvement.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Maven Pet's AI Paw-tnership: Changing Pet Care Landscape

Updated Category News Views 14

AI in the World of Doggie Docs In today's tech-driven world, pet owners are turning to artificial intelligence like never before. Forget flipping through outdated dog-care books—nearly half of us are drilling ChatGPT for health tips on our four-legged pals. Yes, it seems we’re asking an AI about Rover's health more than some other major life decisions. But let's face...

Continue Reading
VetsinTech's AI Training Boosts Military Careers

Updated Category News Views 41

A New Spin on Engineering Careers Sometimes it feels like every corner I turn in this market maze, there’s something about AI. It’s not just chirping in the tech world anymore; it’s banging on the doors of sectors like engineering, aerospace, and manufacturing. And now, VetsinTech is tossing its hat into the AI ring with a fresh program aimed at blending military...

Continue Reading
Special Needs Group Partners with MAST to Enhance Accessibility

Updated Category News Views 23

Accessible Travel Takes the Spotlight Ah, the travel biz—just when you think you’ve got it all figured out, along comes a partnership like this to shake things up. Special Needs Group, the big cheese in mobility and medical equipment rentals, is teaming up with MAST Travel Network. Together, they're rolling out initiatives to make the world a bit more accessible, even...

Continue Reading
Simple Home Upgrades That Boost Value Fast

Updated Category News Views 13

Transform Your Home's Curb Appeal Without Breaking The Bank Every homeowner knows that feeling when you look at your house one day and think, "This could use a little something." Say you're strolling through a neighborhood in Fulton, N.Y., and notice a gem. It's not a brand new build, but it gleams with character. You bet it's had a few smart touches that could apply...

Continue Reading
TechCrunch Disrupt 2026: NYSE and Snowflake Highlights

Updated Category News Views 27

Ever noticed how the air vibrates just a bit more when major players like NYSE and Snowflake start shaking hands at big-league events like TechCrunch Disrupt? You'd better believe we're seeing a fresh brew of opportunities and challenges in the market as these titans lock horns and share insights. It's no small feat when the financial nerve center partners into the tech...

Continue Reading
Celebree Gains Franchise Momentum: A New Frontier

Updated Category News Views 16

The Climb: Celebree Schools on the Rise Here's a nugget in the franchise world that's causing a stir: Celebree School is making moves up the Franchise Times Top 400. When we're talking about a hop, skip, and jump through 84 spots since 2023, you can't help but notice. It's the third year in a row they're climbing this ladder, and it's making ripples. Franchise Expansion...

Continue Reading
Partner Valuation Advisors Bolsters Team with Eichman

Updated Category News Views 8

Eichman Joins Partner Valuation Advisors as MD Turns out the buzz in real estate appraisal isn’t just about property values these days; it's about who's valuing them. Just ask Partner Valuation Advisors, who are realigning their chess pieces by bringing seasoned pro Justin Eichman, MAI, on board as Managing Director. Talk about playing your cards right. A Heavyweight in...

Continue Reading
Montessori and Tech: A New Era of Integration

Updated Category News Views 24

Reimagining Montessori with Technology Let's take a stroll down the road less traveled—the intersection of Montessori education and tech. For over a century, Montessori schools have valued individual child development, autonomy, and a purpose-driven environment. But let's face it, their technology hasn't always had the same handcrafted finesse. That's where illumine...

Continue Reading
OmniActive's Fenavari: A New Era in Women's Health

Updated Category News Views 37

Pioneering Women's Health with Fenavari You ever wonder why some health products get all the hype? Here's one for the book: OmniActive Health Technologies launching Fenavari, their top-tier contender in the women's health market. Now, we're not talking your run-of-the-mill supplement here. We're stepping onto a new playing field, especially with Dr. Taz Bhatia stepping...

Continue Reading
Omneky Outshines Competitors in AI Ad Scoring

Updated Category News Views 34

Brewing a better ad with AI isn't just about the model you plug in—it's about the wizardry wrapping around it. Omneky's latest caper in the AI advertising game has snagged the spotlight, pulling a hearty 8.8 taste score on a recent TasteBench comparison. That's not a minor tweak, folks, but a whopping 1.2-point lead over the shadow-chasing curves of the next...

Continue Reading

Top 5 Most Recently Viewed Articles

Nvidia's Stellar Earnings Amidst Mixed Economic Signals

Updated Category News Views 140

Nvidia Reports Exceptional Third-Quarter Growth Nvidia recently shared its impressive third-quarter results, showcasing a remarkable revenue growth of 62.4%, reaching $57 billion, compared to $35.1 billion in the same quarter last year. This performance exceeded expectations, marking a 3.3% revenue surprise and a 3.2% earnings surprise. Nvidia's CEO, Jensen Huang,...

Continue Reading
Investors of Sage Therapeutics Urged to Review Claims Seriously

Updated Category News Views 49

Attention Sage Therapeutics Investors Investors in Sage Therapeutics, Inc. should take note of an important investigation into potential claims that may warrant attention. With rising concerns regarding the company's operational disclosures, it’s crucial for those affected to understand their options and the potential for recourse. Understanding Your Rights If you are...

Continue Reading
Why Mercedes Dashboard Alerts Demand Quick Action

Updated Category News Views 10

The Critical Role of Dashboard Alerts Cars today are like mobile computers, and nowhere is this truer than with a Mercedes. If you’re in Atlanta navigating the maze of traffic, those dashboard alerts aren't there for decoration. That's the takeaway from expert Josh Anderson, who knows European cars like a book he’s read too many times. Behind the Wheel: Lights Lead to...

Continue Reading
Breach Inlet Capital's Stand Against DAKT's Reincorporation Plan

Updated Category News Views 89

Breach Inlet Capital's Stand Against DAKT's Reincorporation Plan Breach Inlet Capital Management, LLC is an investment firm that specializes in uncovering potential in underfollowed small-cap equities. Recently, they have taken a definitive stance against the proposed reincorporation of Daktronics, Inc. (NASDAQ: DAKT) from South Dakota to Delaware. The firm argues that...

Continue Reading
NOVAGOLD Welcomes Ali Erfan as New Board Director

Updated Category News Views 300

NOVAGOLD Appoints New Member to Board of Directors VANCOUVER, British Columbia — NOVAGOLD RESOURCES INC. (“NOVAGOLD” or the “Company”) (NYSE American, TSX: NG) is excited to announce the addition of Ali Erfan to its Board of Directors, effective immediately. This appointment comes as a result of the recent departure of director Diane Garrett, creating...

Continue Reading